APO Research
Talk to an analyst

APO RESEARCH · REPORT

Natamycin

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Selected research

Industry Growth & Trends

Global Natamycin Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchNatamycin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Natamycin Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Natamycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Natamycin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Natamycin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.

North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.

Read the full market overview

In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

Report Scope

This report provides a structured, data-driven view of the global Natamycin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Natamycin market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Natamycin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Natamycin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Natamycin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Natamycin Market by Company

Danisco

DSM

VGP

Handary

AMTECH BIOTECH

Silver-Elephant

Lanzhou Weiri

Langfang Meihua

Zhengzhou New Frey

Chihon

Jiaozuo Joincare

Beijing Oriental Rada

Pucheng Lifecome

Natamycin Segment by Type

Glucose-based

Lactose-based

Sodium chloride-based

Natamycin Segment by Application

Food

Medical

Others

Natamycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Natamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natamycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Natamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glucose-based Table 2. Major Company of Lactose-based Table 3. Major Company of Sodium chloride-based Table 4. Global Natamycin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Natamycin Sales by Type (2021-2026) & (MT) Table 6. Global Natamycin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Natamycin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Natamycin Sales Market Share in Value by Type (2021-2026) Table 9. Global Natamycin Price by Type (2021-2026) & (USD/MT) Table 10. Global Natamycin Sales by Type (2027-2032) & (MT) Table 11. Global Natamycin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Natamycin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Natamycin Sales Market Share in Value by Type (2027-2032) Table 14. Global Natamycin Price by Type (2027-2032) & (USD/MT) Table 15. North America Natamycin Sales by Type (2021-2026) & (MT) Table 16. North America Natamycin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Natamycin Sales by Type (2021-2026) & (MT) Table 18. Europe Natamycin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Natamycin Sales by Type (2021-2026) & (MT) Table 20. Asia-Pacific Natamycin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Natamycin Sales by Type (2021-2026) & (MT) Table 22. Latin America Natamycin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Natamycin Sales by Type (2021-2026) & (MT) Table 24. Middle East and Africa Natamycin Sales by Type (2021-2026) & (US$ Million) Table 25. Natamycin Industry Trends Table 26. Natamycin Industry Drivers Table 27. Natamycin Industry Opportunities and Challenges Table 28. Natamycin Industry Restraints Table 29. Global Natamycin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Natamycin Revenue Market Share by Company (2021-2026) Table 31. Global Natamycin Sales by Company (2021-2026) & (MT) Table 32. Global Natamycin Sales Share by Company (2021-2026) Table 33. Global Natamycin Market Price by Company (2021-2026) & (USD/MT) Table 34. Global Natamycin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Natamycin Major Company Production Sites and Headquarters Table 36. Global Natamycin Company, Product Type & Application Table 37. Global Natamycin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Natamycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Natamycin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Natamycin Sales by Region (2021-2026) & (MT) Table 42. Global Natamycin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Natamycin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Natamycin Sales Market Share in Value by Region (2021-2026) Table 45. Global Natamycin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 46. Global Natamycin Sales by Region (2027-2032) & (MT) Table 47. Global Natamycin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Natamycin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Natamycin Sales Market Share in Value by Region (2027-2032) Table 50. Global Natamycin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 51. Global Natamycin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Natamycin Sales by Application (2021-2026) & (MT) Table 53. Global Natamycin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Natamycin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Natamycin Sales Market Share in Value by Application (2021-2026) Table 56. Global Natamycin Price by Application (2021-2026) & (USD/MT) Table 57. Global Natamycin Sales by Application (2027-2032) & (MT) Table 58. Global Natamycin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Natamycin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Natamycin Sales Market Share in Value by Application (2027-2032) Table 61. Global Natamycin Price by Application (2027-2032) & (USD/MT) Table 62. North America Natamycin Sales by Application (2021-2026) & (MT) Table 63. North America Natamycin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Natamycin Sales by Application (2021-2026) & (MT) Table 65. Europe Natamycin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Natamycin Sales by Application (2021-2026) & (MT) Table 67. Asia-Pacific Natamycin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Natamycin Sales by Application (2021-2026) & (MT) Table 69. Latin America Natamycin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Natamycin Sales by Application (2021-2026) & (MT) Table 71. Middle East and Africa Natamycin Sales by Application (2021-2026) & (US$ Million) Table 72. Danisco Company Information Table 73. Danisco Business Overview Table 74. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 75. Danisco Natamycin Product Portfolio Table 76. Danisco Recent Development Table 77. DSM Company Information Table 78. DSM Business Overview Table 79. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 80. DSM Natamycin Product Portfolio Table 81. DSM Recent Development Table 82. VGP Company Information Table 83. VGP Business Overview Table 84. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 85. VGP Natamycin Product Portfolio Table 86. VGP Recent Development Table 87. Handary Company Information Table 88. Handary Business Overview Table 89. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 90. Handary Natamycin Product Portfolio Table 91. Handary Recent Development Table 92. AMTECH BIOTECH Company Information Table 93. AMTECH BIOTECH Business Overview Table 94. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 95. AMTECH BIOTECH Natamycin Product Portfolio Table 96. AMTECH BIOTECH Recent Development Table 97. Silver-Elephant Company Information Table 98. Silver-Elephant Business Overview Table 99. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 100. Silver-Elephant Natamycin Product Portfolio Table 101. Silver-Elephant Recent Development Table 102. Lanzhou Weiri Company Information Table 103. Lanzhou Weiri Business Overview Table 104. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 105. Lanzhou Weiri Natamycin Product Portfolio Table 106. Lanzhou Weiri Recent Development Table 107. Langfang Meihua Company Information Table 108. Langfang Meihua Business Overview Table 109. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 110. Langfang Meihua Natamycin Product Portfolio Table 111. Langfang Meihua Recent Development Table 112. Zhengzhou New Frey Company Information Table 113. Zhengzhou New Frey Business Overview Table 114. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 115. Zhengzhou New Frey Natamycin Product Portfolio Table 116. Zhengzhou New Frey Recent Development Table 117. Chihon Company Information Table 118. Chihon Business Overview Table 119. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 120. Chihon Natamycin Product Portfolio Table 121. Chihon Recent Development Table 122. Jiaozuo Joincare Company Information Table 123. Jiaozuo Joincare Business Overview Table 124. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 125. Jiaozuo Joincare Natamycin Product Portfolio Table 126. Jiaozuo Joincare Recent Development Table 127. Beijing Oriental Rada Company Information Table 128. Beijing Oriental Rada Business Overview Table 129. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 130. Beijing Oriental Rada Natamycin Product Portfolio Table 131. Beijing Oriental Rada Recent Development Table 132. Pucheng Lifecome Company Information Table 133. Pucheng Lifecome Business Overview Table 134. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 135. Pucheng Lifecome Natamycin Product Portfolio Table 136. Pucheng Lifecome Recent Development Table 137. North America Natamycin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 138. North America Natamycin Sales by Country (2021-2026) & (MT) Table 139. North America Natamycin Sales Market Share by Country (2021-2026) Table 140. North America Natamycin Sales Forecast by Country (2027-2032) & (MT) Table 141. North America Natamycin Sales Market Share Forecast by Country (2027-2032) Table 142. North America Natamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Natamycin Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Natamycin Market Share by Country (2021-2026) Table 145. North America Natamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Natamycin Market Share Forecast by Country (2027-2032) Table 147. Europe Natamycin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 148. Europe Natamycin Sales by Country (2021-2026) & (MT) Table 149. Europe Natamycin Sales Market Share by Country (2021-2026) Table 150. Europe Natamycin Sales Forecast by Country (2027-2032) & (MT) Table 151. Europe Natamycin Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Natamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Natamycin Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Natamycin Market Share by Country (2021-2026) Table 155. Europe Natamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Natamycin Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Natamycin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Natamycin Sales by Country (2021-2026) & (MT) Table 159. Asia-Pacific Natamycin Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Natamycin Sales Forecast by Country (2027-2032) & (MT) Table 161. Asia-Pacific Natamycin Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Natamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Natamycin Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Natamycin Market Share by Country (2021-2026) Table 165. Asia-Pacific Natamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Natamycin Market Share Forecast by Country (2027-2032) Table 167. Latin America Natamycin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 168. Latin America Natamycin Sales by Country (2021-2026) & (MT) Table 169. Latin America Natamycin Sales Market Share by Country (2021-2026) Table 170. Latin America Natamycin Sales Forecast by Country (2027-2032) & (MT) Table 171. Latin America Natamycin Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Natamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Natamycin Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Natamycin Market Share by Country (2021-2026) Table 175. Latin America Natamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Natamycin Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Natamycin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Natamycin Sales by Country (2021-2026) & (MT) Table 179. Middle East and Africa Natamycin Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Natamycin Sales Forecast by Country (2027-2032) & (MT) Table 181. Middle East and Africa Natamycin Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Natamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Natamycin Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Natamycin Market Share by Country (2021-2026) Table 185. Middle East and Africa Natamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Natamycin Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Natamycin Distributors List Table 190. Natamycin Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Natamycin Image Figure 2. Global Natamycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Natamycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Natamycin Sales (2021-2032) & (MT) Figure 5. Glucose-based Image Figure 6. Global Glucose-based Sales YoY Growth (2021-2032) & (MT) Figure 7. Lactose-based Image Figure 8. Global Lactose-based Sales YoY Growth (2021-2032) & (MT) Figure 9. Sodium chloride-based Image Figure 10. Global Sodium chloride-based Sales YoY Growth (2021-2032) & (MT) Figure 11. Global Natamycin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Natamycin Market Share by Type 2025 VS 2032 Figure 13. North America Natamycin Sales Market Share in Volume by Type in 2025 Figure 14. North America Natamycin Sales Market Share in Value by Type in 2025 Figure 15. Europe Natamycin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Natamycin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Natamycin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Natamycin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Natamycin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Natamycin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Natamycin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Natamycin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Natamycin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Food Image Figure 26. Global Food Sales YoY Growth (2021-2032) & (MT) Figure 27. Medical Image Figure 28. Global Medical Sales YoY Growth (2021-2032) & (MT) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 31. Global Natamycin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Natamycin Market Share by Application 2025 VS 2032 Figure 33. North America Natamycin Sales Market Share in Volume by Application in 2025 Figure 34. North America Natamycin Sales Market Share in Value by Application in 2025 Figure 35. Europe Natamycin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Natamycin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Natamycin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Natamycin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Natamycin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Natamycin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Natamycin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Natamycin Sales Market Share in Value by Application in 2025 Figure 43. North America Natamycin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 44. North America Natamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Natamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Natamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Natamycin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. Europe Natamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Natamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Natamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Natamycin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Asia-Pacific Natamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Natamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Natamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Natamycin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Latin America Natamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Natamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Natamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Natamycin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 60. Middle East and Africa Natamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Natamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Natamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Natamycin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Natamycin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Glucose-based
  • Lactose-based
  • Sodium chloride-based
Applications
  • Food
  • Medical
  • Others
Companies covered
  • Danisco
  • DSM
  • VGP
  • Handary
  • AMTECH BIOTECH
  • Silver-Elephant
  • Lanzhou Weiri
  • Langfang Meihua
  • Zhengzhou New Frey
  • Chihon
  • Jiaozuo Joincare
  • Beijing Oriental Rada
  • Pucheng Lifecome

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Natamycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Natamycin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Natamycin Market by Type
  6. 1.3.1 Glucose-based
  7. 1.3.2 Lactose-based
  8. 1.3.3 Sodium chloride-based
  9. 1.4 Global Natamycin Market Size by Type
  10. 1.4.1 Global Natamycin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Natamycin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Natamycin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Natamycin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Natamycin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Natamycin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Natamycin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Natamycin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Natamycin Industry Trends
  2. 2.2 Natamycin Industry Drivers
  3. 2.3 Natamycin Industry Opportunities and Challenges
  4. 2.4 Natamycin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Natamycin Revenue (2021-2026)
  2. 3.2 Global Top Players by Natamycin Sales (2021-2026)
  3. 3.3 Global Top Players by Natamycin Price (2021-2026)
  4. 3.4 Global Natamycin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Natamycin Major Company Production Sites & Headquarters
  6. 3.6 Global Natamycin Company, Product Type & Application
  7. 3.7 Global Natamycin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Natamycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Natamycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Natamycin Tier 1, Tier 2, and Tier 3
4 Natamycin Regional Status and Outlook
  1. 4.1 Global Natamycin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Natamycin Historic Market Size by Region
  3. 4.2.1 Global Natamycin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Natamycin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Natamycin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Natamycin Forecasted Market Size by Region
  7. 4.3.1 Global Natamycin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Natamycin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Natamycin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Natamycin by Application
  1. 5.1 Natamycin Market by Application
  2. 5.1.1 Food
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Natamycin Market Size by Application
  6. 5.2.1 Global Natamycin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Natamycin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Natamycin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Natamycin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Natamycin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Natamycin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Natamycin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Natamycin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Danisco
  2. 6.1.1 Danisco Company Information
  3. 6.1.2 Danisco Business Overview
  4. 6.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Danisco Natamycin Product Portfolio
  6. 6.1.5 Danisco Recent Developments
  7. 6.2 DSM
  8. 6.2.1 DSM Company Information
  9. 6.2.2 DSM Business Overview
  10. 6.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 DSM Natamycin Product Portfolio
  12. 6.2.5 DSM Recent Developments
  13. 6.3 VGP
  14. 6.3.1 VGP Company Information
  15. 6.3.2 VGP Business Overview
  16. 6.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 VGP Natamycin Product Portfolio
  18. 6.3.5 VGP Recent Developments
  19. 6.4 Handary
  20. 6.4.1 Handary Company Information
  21. 6.4.2 Handary Business Overview
  22. 6.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Handary Natamycin Product Portfolio
  24. 6.4.5 Handary Recent Developments
  25. 6.5 AMTECH BIOTECH
  26. 6.5.1 AMTECH BIOTECH Company Information
  27. 6.5.2 AMTECH BIOTECH Business Overview
  28. 6.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AMTECH BIOTECH Natamycin Product Portfolio
  30. 6.5.5 AMTECH BIOTECH Recent Developments
  31. 6.6 Silver-Elephant
  32. 6.6.1 Silver-Elephant Company Information
  33. 6.6.2 Silver-Elephant Business Overview
  34. 6.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Silver-Elephant Natamycin Product Portfolio
  36. 6.6.5 Silver-Elephant Recent Developments
  37. 6.7 Lanzhou Weiri
  38. 6.7.1 Lanzhou Weiri Company Information
  39. 6.7.2 Lanzhou Weiri Business Overview
  40. 6.7.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lanzhou Weiri Natamycin Product Portfolio
  42. 6.7.5 Lanzhou Weiri Recent Developments
  43. 6.8 Langfang Meihua
  44. 6.8.1 Langfang Meihua Company Information
  45. 6.8.2 Langfang Meihua Business Overview
  46. 6.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Langfang Meihua Natamycin Product Portfolio
  48. 6.8.5 Langfang Meihua Recent Developments
  49. 6.9 Zhengzhou New Frey
  50. 6.9.1 Zhengzhou New Frey Company Information
  51. 6.9.2 Zhengzhou New Frey Business Overview
  52. 6.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zhengzhou New Frey Natamycin Product Portfolio
  54. 6.9.5 Zhengzhou New Frey Recent Developments
  55. 6.10 Chihon
  56. 6.10.1 Chihon Company Information
  57. 6.10.2 Chihon Business Overview
  58. 6.10.3 Chihon Natamycin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chihon Natamycin Product Portfolio
  60. 6.10.5 Chihon Recent Developments
  61. 6.11 Jiaozuo Joincare
  62. 6.11.1 Jiaozuo Joincare Company Information
  63. 6.11.2 Jiaozuo Joincare Business Overview
  64. 6.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jiaozuo Joincare Natamycin Product Portfolio
  66. 6.11.5 Jiaozuo Joincare Recent Developments
  67. 6.12 Beijing Oriental Rada
  68. 6.12.1 Beijing Oriental Rada Company Information
  69. 6.12.2 Beijing Oriental Rada Business Overview
  70. 6.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Beijing Oriental Rada Natamycin Product Portfolio
  72. 6.12.5 Beijing Oriental Rada Recent Developments
  73. 6.13 Pucheng Lifecome
  74. 6.13.1 Pucheng Lifecome Company Information
  75. 6.13.2 Pucheng Lifecome Business Overview
  76. 6.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pucheng Lifecome Natamycin Product Portfolio
  78. 6.13.5 Pucheng Lifecome Recent Developments
7 North America by Country
  1. 7.1 North America Natamycin Sales by Country
  2. 7.1.1 North America Natamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Natamycin Sales by Country (2021-2026)
  4. 7.1.3 North America Natamycin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Natamycin Market Size by Country
  6. 7.2.1 North America Natamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Natamycin Market Size by Country (2021-2026)
  8. 7.2.3 North America Natamycin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Natamycin Sales by Country
  2. 8.1.1 Europe Natamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Natamycin Sales by Country (2021-2026)
  4. 8.1.3 Europe Natamycin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Natamycin Market Size by Country
  6. 8.2.1 Europe Natamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Natamycin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Natamycin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Natamycin Sales by Country
  2. 9.1.1 Asia-Pacific Natamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Natamycin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Natamycin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Natamycin Market Size by Country
  6. 9.2.1 Asia-Pacific Natamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Natamycin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Natamycin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Natamycin Sales by Country
  2. 10.1.1 South America Natamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Natamycin Sales by Country (2021-2026)
  4. 10.1.3 South America Natamycin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Natamycin Market Size by Country
  6. 10.2.1 South America Natamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Natamycin Market Size by Country (2021-2026)
  8. 10.2.3 South America Natamycin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Natamycin Sales by Country
  2. 11.1.1 Middle East and Africa Natamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Natamycin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Natamycin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Natamycin Market Size by Country
  6. 11.2.1 Middle East and Africa Natamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Natamycin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Natamycin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Natamycin Value Chain Analysis
  2. 12.1.1 Natamycin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Natamycin Production Mode & Process
  7. 12.2 Natamycin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Natamycin Distributors
  10. 12.2.3 Natamycin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst